Ubs Asset Management Americas Inc Moderna, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 3,023,227 shares of MRNA stock, worth $77.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,023,227
Previous 3,597,236
15.96%
Holding current value
$77.6 Million
Previous $102 Million
18.21%
% of portfolio
0.02%
Previous 0.03%
Shares
23 transactions
Others Institutions Holding MRNA
# of Institutions
860Shares Held
267MCall Options Held
28.5MPut Options Held
34.8M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.07 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$656 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$567 Million0.48% of portfolio
-
State Street Corp Boston, MA17.3MShares$443 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$228 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...